Role of Metabolomics in Personalized Medicine

  • Kewal K. JainEmail author


The human metabolome is best understood by analogy to the human genome, i.e., where the human genome is the set of all genes in a human being, the human metabolome is the set of all metabolites in a human being. In a systems biology approach, metabolomics provides a functional readout of changes determined by the genetic blueprint, regulation, protein abundance and modification, and environmental influence. Metabolomics is the study of the small molecules, or metabolites, contained in a human cell, tissue, or organ (including fluids) and involved in primary and intermediary metabolism. By definition, the metabolome should exclude enzymes, genetic material and structural molecules such as glycosaminoglycans, and other polymeric units that are degraded to small molecules but do not otherwise participate in metabolic reactions. A related term, metabonomics is the use of nuclear magnetic resonance (NMR) technology to study metabolomics. According to the Metabolomics Society, “Metabolomics is the study of metabolic changes. It encompasses metabolomics, metabolite target analysis, metabolite profiling, metabolic fingerprinting, metabolic profiling, and metabonomics”. Examination of a sample using multiple mass spectrometry-based technologies, nuclear magnetic resonance, integration of the data, and analysis by proprietary software and algorithms enables faster and more accurate understanding of a disease than previously possible. In spite of the broader scope of metabolomics to include metabonomics, the two terms still continue to be used interchangeably.


Nuclear Magnetic Resonance Metabolic Profile Metabolite Profile Independent Component Analysis Personalize Nutrition 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. Bijlsma S, Bobeldijk I, Verheij ER et al (2006) Large-scale human metabolomics studies: a strategy for data (pre-) processing and validation. Anal Chem 78:567–74CrossRefPubMedGoogle Scholar
  2. Clayton TA, Lindon JC, Cloarec O et al (2006) Pharmaco-metabonomic phenotyping and personalized drug treatment. Nature 440:1073–1077CrossRefPubMedGoogle Scholar
  3. Gieger C, Geistlinger L, Altmaier E et al (2008) Genetics meets metabolomics: a genome-wide association study of metabolite profiles in human serum. PLoS Genet 4(11):e1000282.CrossRefPubMedGoogle Scholar
  4. Haselden JN, Nicholls AW (2006) Personalized medicine progresses. Nat Med 12:510–511CrossRefPubMedGoogle Scholar
  5. Hunter P (2009) Reading the metabolic fine print. The application of metabolomics to diagnostics, drug research and nutrition might be integral to improved health and personalized medicine. EMBO Rep 10:20–23CrossRefPubMedGoogle Scholar
  6. Schwudke D, Oegema J, Burton L et al (2006) Lipid profiling by multiple precursor and neutral loss scanning driven by the data-dependent acquisition. Anal Chem 78:585–595CrossRefPubMedGoogle Scholar
  7. Weckwerth W, Morgenthal K (2005) Metabolomics: from pattern recognition to biological interpretation. Drug Discov Today 10:1551–1558CrossRefPubMedGoogle Scholar
  8. Wishart DS, Tzur D, Knox C et al (2007) HMDB: the human metabolome database. Nucl Acids Res 35(Database issue):D521–D526CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2009

Authors and Affiliations

  1. 1.Jain PharmaBiotechBaselSwitzerland

Personalised recommendations